
Sign up to save your podcasts
Or


Doddie and Jill are joined by the My Name'5 Doddie Foundation's medical strategy lead Sean McGrath and Professor Ammar Al-Chalabi of King’s College London to discuss clinical trial design, biomarkers, gene therapy and stem cell research, as well as complementary therapies, and there is a real sense of optimism that a cure for MND is closer than we might think. Supported by Aberdeen Standard Investments.
By Tim GrovesDoddie and Jill are joined by the My Name'5 Doddie Foundation's medical strategy lead Sean McGrath and Professor Ammar Al-Chalabi of King’s College London to discuss clinical trial design, biomarkers, gene therapy and stem cell research, as well as complementary therapies, and there is a real sense of optimism that a cure for MND is closer than we might think. Supported by Aberdeen Standard Investments.